Your browser doesn't support javascript.
loading
Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis.
Hada, Manila; Mosholder, Andrew D; Leishear, Kira; Perez-Vilar, Silvia.
Affiliation
  • Hada M; Division of Epidemiology I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Room 2481, Silver Spring, MD, 20993-0002, USA.
  • Mosholder AD; Division of Epidemiology I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Room 2481, Silver Spring, MD, 20993-0002, USA.
  • Leishear K; Division of Epidemiology I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Room 2481, Silver Spring, MD, 20993-0002, USA.
  • Perez-Vilar S; Division of Epidemiology I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Room 2481, Silver Spring, MD, 20993-0002, USA. silvia.perezvilar@fda.hhs.gov.
Neurol Sci ; 43(3): 1557-1567, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35006442

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: United States